Table 3.
Cholesterol efflux | Fluidity | |||
---|---|---|---|---|
|
||||
Variable (3-week changes) | R | P value | R | P value |
Cholesterol efflux, % | 1 | 1 | 0.308 | 0.004 |
Fluidity, 1/anisotropy (AU) | 0.308 | 0.004 | 1 | 1 |
HDL Composition | ||||
Fatty acids in HDL, % | ||||
Arachidonic | 0.043 | 0.700 | 0.097 | 0.387 |
Eicosatreanoic | 0.084 | 0.456 | 0.033 | 0.768 |
Linoleic | −0.235 | 0.034 | 0.057 | 0.613 |
Oleic | 0.025 | 0.823 | 0.004 | 0.972 |
Palmitic | 0.128 | 0.256 | −0.155 | 0.156 |
Stearic | 0.328 | 0.003 | 0.140 | 0.213 |
Proteins in HDL, g/L | ||||
Apolipoprotein A-I | 0.309 | 0.004 | 0.123 | 0.264 |
Apolipoprotein A-II | 0.364 | 0.001 | 0.070 | 0.537 |
Lipids in HDL, mg/dL | ||||
Total Cholesterol | 0.287 | 0.008 | −0.010 | 0.927 |
Free Cholesterol | 0.073 | 0.509 | −0.322 | 0.003 |
Esterified Cholesterol | 0.225 | 0.040 | 0.229 | 0.036 |
Triglycerides | 0.251 | 0.021 | 0.383 | <0.001 |
Phospholipids | 0.382 | <0.001 | 0.186 | 0.091 |
Triglycerides in HDL core* | −0.041 | 0.713 | 0.220 | 0.044 |
Oxidative/Antioxidative status of HDL | ||||
Oxidative status† | ||||
Lag time, min | 0.331 | 0.006 | −0.049 | 0.606 |
Maxim absorbance, Abs | 0.053 | 0.708 | 0.125 | 0.375 |
Oxidation rate, Abs/s | −0.168 | 0.189 | 0.175 | 0.215 |
Antioxidative status of HDL, µmol/L | ||||
α-tocopherol | −0.021 | 0.859 | −0.001 | 0.903 |
γ-tocopherol | −0.022 | 0.850 | 0.069 | 0.549 |
β-carotene | 0.044 | 0.701 | 0.016 | 0.892 |
β-cryptoxanthin | 0.306 | 0.008 | 0.034 | 0.772 |
Coenzime-Q | 0.128 | 0.291 | 0.075 | 0.539 |
Luteine | 0.211 | 0.066 | 0.065 | 0.575 |
Retinol | 0.158 | 0.170 | −0.179 | 0.120 |
Phenolic compounds‡ | 0.138 | 0.182 | 0.127 | 0.271 |
PON1 activity, U/L | 0.139 | 0.210 | 0.108 | 0.332 |
HDL particle size, µmol/L | ||||
HDL mean size (total)¥ | 0.076 | 0.494 | 0.379 | <0.001 |
Small HDL particles | −0.349 | 0.001 | −0.635 | <0.001 |
Medium HDL particles | 0.273 | 0.012 | 0.241 | 0.027 |
Large HDL particles | 0.224 | 0.041 | 0.155 | 0.158 |
AU, arbitrary units. PON1, Paraoxonase-1.
Calculated as triglycerides/esterified cholesterol ratio.
Conjugated dienes formation curve.
nmol/L.
nanometers